pivalyloxymethyl butyrate has been researched along with 4-aminophenylphosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aviram, A; Nudelman, A; Rephaeli, A; Shaklai, M; Zimrah, Y | 1 |
| Eisenbach, L; Nudelman, A; Rabizadeh, E; Rephaeli, A; Shaklai, M | 1 |
2 other study(ies) available for pivalyloxymethyl butyrate and 4-aminophenylphosphate
| Article | Year |
|---|---|
Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL-60 leukemic cell line.
Topics: Acetylation; Aniline Compounds; Butyrates; Butyric Acid; Histones; Leukemia, Promyelocytic, Acute; Organophosphorus Compounds; Prodrugs; Tumor Cells, Cultured | 1994 |
Esterase inhibitors diminish the modulation of gene expression by butyric acid derivative, pivaloyloxymethyl butyrate (AN-9).
Topics: Aniline Compounds; Antineoplastic Agents; Butyrates; Butyric Acid; Drug Antagonism; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Genes, jun; Genes, myc; HL-60 Cells; Humans; Organophosphorus Compounds; Phenylmethylsulfonyl Fluoride; Premedication | 1996 |